**US24665A1034 - Common Stock - After market: 23.14 0 (0%)**

Taking everything into account, **DK** scores **5** out of 10 in our fundamental rating. **DK** was compared to 385 industry peers in the **Oil, Gas & Consumable Fuels** industry. **DK** has a medium financial health rating, its profitability is only medium as well. **DK** is valued quite cheap, while showing a decent growth score. This is a good combination!

The Piotroski-F score of **DK** is **8.00**. This is a very strong score and indicates great health and profitability for **DK**.

ROA (3.14%) VS Industry: 17% outperformed.

0.06

1,708.00

ROE (27.25%) VS Industry: 48% outperformed.

0.30

19,161.80

Profit Margin (1.27%) VS Industry: 3% outperformed.

0.07

334.14

The **Price/Earnings Ratio** is **3.94**, which indicates a rather cheap valuation of **DK**.

With a **Forward Price/Earnings Ratio** of **6.00**, the valuation of **DK** can be described as cheap.

The low **PEG Ratio**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

With a price book ratio of **1.64**, **DK** is valued correctly.

When comparing the price book ratio of **DK** to the average industry price book ratio of 1.45, **DK** is valued in line with its industry peers.

Compared to an average industry **Enterprise Value to EBITDA** ratio of 3.70, **DK** is valued more expensive than its industry peers.

Price/Earnings (3.94) VS Industry: 70% outperformed.

4,750.00

0.01

Price/Book (1.64) VS Industry: 42% outperformed.

3,984.80

0.04

Enterprise Value/ EBITDA (5) VS Industry: 40% outperformed.

227.31

0.12

Measured over the past 5 years, **DK** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **44.92%** on average per year.

The **Revenue** has grown by **90.13%** in the past year. This is a very strong growth!

The **Revenue** has been growing by **22.74%** on average over the past 5 years. This is a very strong growth!

The **Earnings Per Share** is expected to decrease by **-16.53%** on average over the next 5 years. This is quite bad

When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | 44.92% | 20.27% | 292.79% | -34.39% | -37.22% | -47.63% | -16.53% |

Revenue | 22.74% | 29.61% | 90.13% | -32.25% | -19.08% | -20.88% | N/A |

The Altman-Z score of **DK** is much better than the industry average of **2.05**.

The Piotroski-F score of **DK** is **8.00**. This is a very strong score and indicates great health and profitability for **DK**.

A Quick Ratio of **0.71** indicates that **DK** may have some problems paying its short term obligations.

Compared to an average industry Quick Ratio of 1.01, **DK** is worse placed to pay its short term obligations than its industry peers.

Debt/Equity (3.16) VS Industry: 4% outperformed.

78.08

0.00

Quick Ratio (0.71) VS Industry: 31% outperformed.

0.00

279.52

Current Ratio (1.2) VS Industry: 52% outperformed.

0.00

279.52

Altman-Z (2.97) VS Industry: 64% outperformed.

-283,883.16

804.85

Compared to an average S&P500 **Dividend Yield** of **2.60**, **DK** pays a bit more dividend than the S&P500 average.

Dividend Yield (3.19%) VS Industry: 28% outperformed.

0.32

64.51

NYSE:DK (3/29/2023, 7:04:00 PM)**-0.35 (-1.49%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)02-28 2023-02-28/bmo

Earnings (Next)05-01 2023-05-01/bmo

Inst Owners96.56%

Inst Owner Change-2.46%

Ins Owners1.06%

Ins Owner Change14.81%

Market Cap1.55B

Analysts51.43

Price Target32.83 (41.88%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.19% |

Dividend Growth(5Y)N/A

DP16.65%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-Date03-09 2023-03-09 (0.22)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-34.62%

Min EPS beat(2)-74.39%

Max EPS beat(2)5.16%

EPS beat(4)3

Avg EPS beat(4)136.05%

Min EPS beat(4)-74.39%

Max EPS beat(4)582.77%

Revenue beat(2)2

Avg Revenue beat(2)37.06%

Min Revenue beat(2)31.55%

Max Revenue beat(2)42.57%

Revenue beat(4)4

Avg Revenue beat(4)41.25%

Min Revenue beat(4)31.55%

Max Revenue beat(4)46.73%

PT rev (1m)1.14%

PT rev (3m)-8.05%

EPS NQ rev (1m)-9.56%

EPS NQ rev (3m)-19.13%

EPS NY rev (1m)-13.1%

EPS NY rev (3m)-13.1%

Revenue NQ rev (1m)-14.74%

Revenue NQ rev (3m)-24.89%

Revenue NY rev (1m)-8.2%

Revenue NY rev (3m)-8.2%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 3.94 | ||

Fwd PE | 6 | ||

P/S | 0.08 | ||

P/FCF | 14.3 | ||

P/OCF | 3.64 | ||

P/B | 1.64 | ||

P/tB | N/A | ||

EV/EBITDA | 5 |

EPS(TTM)5.88

EY25.41%

EPS(NY)3.86

Fwd EY16.67%

FCF(TTM)1.62

FCFY6.99%

OCF(TTM)6.35

OCFY27.46%

SpS302.44

BVpS14.1

TBVpS-1.74

PEG (NY)N/A

PEG (5Y)0.09

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.14% | ||

ROE | 27.25% | ||

ROIC | 7.54% | ||

ROICexc | 9.02% | ||

ROICexgc | 12.01% | ||

OM | 2.32% | ||

PM | 1.27% | ||

GM | 9.39% |

ROICexgc(3y)N/A

ROICexcg growth 3Y-7.98%

ROICexcg growth 5Y-3.85%

ROICexc(3y)N/A

ROICexc growth 3Y-7.48%

ROICexc growth 5Y0.37%

OM growth 3Y-25.19%

OM growth 5Y-7.73%

PM growth 3Y-27.59%

PM growth 5Y-20.41%

GM growth 3Y-19.34%

GM growth 5Y-7.58%

F-Score8

Asset Turnover2.47

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 3.16 | ||

Debt/FCF | 28.2 | ||

Debt/EBITDA | 4.04 | ||

Cap/Depr | 110.45% | ||

Profit Quality | 42.12% | ||

Current Ratio | 1.2 | ||

Quick Ratio | 0.71 | ||

Altman-Z | 2.97 |

F-Score8

WACC9.26%

ROIC/WACC1.3

Cap/Depr(3y)98.84%

Cap/Depr(5y)137.16%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y292.79%

EPS 3Y20.27%

EPS 5Y44.92%

EPS growth Q2Q244.26%

EPS Next Y-34.39%

EPS Next 2Y-37.22%

EPS Next 3Y-47.63%

EPS Next 5Y-16.53%

Revenue growth 1Y90.13%

Revenue growth 3Y29.61%

Revenue growth 5Y22.74%

Revenue growth Q2Q44.12%

Revenue Next Year-32.25%

Revenue Next 2Y-19.08%

Revenue Next 3Y-20.88%

Revenue Next 5YN/A

EBIT growth 1Y676.07%

EBIT growth 3Y-3.04%

EBIT growth 5Y13.25%

EBIT Next Year21.3%

EBIT Next 3Y-4.34%

EBIT Next 5Y-8.03%

FCF growth 1Y-26.92%

FCF growth 3Y-6.92%

FCF growth 5Y-5.3%

OCF growth 1Y14.51%

OCF growth 3Y-9.57%

OCF growth 5Y5.87%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*